Herrington, W. G., Preiss, D., Haynes, R., von Eynatten, M., Staplin, N., Hauske, S. J., . . . Wanner, C. (2019). The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: A rationale for the EMPA-KIDNEY study. Clin Kidney J.

Herrington, William G., et al. "The Potential for Improving Cardio-renal Outcomes By Sodium-glucose Co-transporter-2 Inhibition in People With Chronic Kidney Disease: A Rationale for the EMPA-KIDNEY Study." Clin Kidney J 2019.

Herrington, William G., et al. "The Potential for Improving Cardio-renal Outcomes By Sodium-glucose Co-transporter-2 Inhibition in People With Chronic Kidney Disease: A Rationale for the EMPA-KIDNEY Study." Clin Kidney J 2019.